Background
==========

To share our experience in second line Anti Retroviral Therapy (ART) at State AIDS Clinical Expert Panel (SACEP) Clinic, Centre of Excellence (CoE), ART Centre, B. J. Medical College, Civil Hospital, Ahmedabad, Gujarat, India.

Methods
=======

First line treatment failure Patients (as per Indian National ART Guidelines) were referred to SACEP Clinic for further evaluation and if eligible as per Indian National 2^nd^Line ART Guidelines; enrolled and followed up for initiation of 2^nd^Line ART at our institute.

Results
=======

Provision of Free 2^nd^Line ART to People Living with HIV/AIDS (PLHA) Program by National AIDS Control Organization (NACO), India was started in November, 2008 under SACEP Clinic for Gujarat and Rajasthan PLHAs. Till October 2009 total 127 1^st^Line ART Failure patients were referred to SACEP Clinic, Table [1](#T1){ref-type="table"}.

  Parameter                                                                     Outcome                                              
  ----------------------------------------------------------------------------- -------------------------------- ------------------- -------
  Total Patients referred to SACEP                                              127                                                  
  Patients Eligible and referred for Plasma Viral Load (PVL) (n = 127)          122(96.06%)                                          
  Patients recommended 2^nd^Line ART after PVL (n = 122)                        75(61.47%)                                           
  Patients initiated Free 2^nd^Line ART (n = 75)                                69(92.0%)                                            
  Patients under follow up TB Treatment/Counseling to initiate 2^nd^Line ART    6                                                    
  Adherence Counseling for 2^nd^Line ART Patients (n = 69)                      69(100%)                                             
  Undetectable PVL (\<400 copies/ml) after 6 months of 2^nd^Line ART (n = 28)   24                                                   
  Therapeutic Success according to Undetectable PVL (24/28)                     85.74%                                               
  No. of Death after initiation of 2^nd^Line ART (n = 69)                       8(11.59%)                                            
  Death Analysis                                                                Cause of Death                   WHO Stage/PVL/CD4   n = 8
                                                                                Accidental                       T3/560459/17        1
                                                                                Renal Failure                    T3/208048/230       1
                                                                                Malignancy                       T4/384469/38        1
                                                                                Opportunistic Infections (OIs)   T3/46453/67         4
                                                                                                                 T4/507495/26        
                                                                                                                 T4/1166325/32       
                                                                                                                 T4/289375/21        
                                                                                Unknown Reason                   T3/4095718/29       1

Discussion
==========

Switching to 2^nd^Line ART based on Immunological Failure, Clinical Failure is not recommended; as out of 122 PLHAs analyzed only 75 PLHAs have Virological Failure. Adherence Counseling for 2^nd^Line ART helps quite in reduction of PVL. Deaths analysis shows that late switch to 2^nd^Line ART at CD4 \< 100 cells/mm^3^may not result in desired therapeutic goals.
